OUTLINE:
*Each target price is (1) computed using CGFS' proprietary valuation and simulation approach and (2) adjusted within 3 standard errors of the estimate. Assumption and computation details are inserted at the end of each write-up.
This Weeks Picks:
- Our Weekly Stock Picks
*Each target price is (1) computed using CGFS' proprietary valuation and simulation approach and (2) adjusted within 3 standard errors of the estimate. Assumption and computation details are inserted at the end of each write-up.
This Weeks Picks:
Neurocrine Biosciences, Inc. is a biopharmaceutical company headquartered in San Diego, California. Neurocrine focuses on researching and developing treatments for neurological and endocrine related disorders. Among their marketable products is INGREZZA, an FDA-approved medication indicated for the treatment of adults with an involuntary movement disorder known as tardive dyskinesia. Also developed through Phase II clinical trials by Neurocrine is ORILISSA, an oral medication for the management of endometriosis.
Lululemon Athletica, Inc. is a Canadian athletic apparel company headquartered in Vancouver, British Columbia. Lululemon designs, distributes, and retails athletic apparel for women and men globally. Their products include pants, shorts, tops, jackets, bags, shoes, socks, underwear, yoga mats, and water bottles. Lululemon sells it products through company-operated stores and outlets, as well as through a network of wholesale accounts such as yoga studios, health clubs, and fitness centers. The company also sells directly to the consumer on its website and mobile app.
Pfenex Inc. is a biotechnology company based in San Diego, California. Through their Pfenex Expression Technology, this company seeks to develop and improve high value protein based therapeutics and vaccines. Pfenex's lead products include a therapeutic equivalent drug candidate to Forteo for the treatment of osteoporosis. They have also developed two novel anthrax vaccines referred to as Px563L and RPA563 that have completed Phase I clinical study.
Cardlytics, Inc. is a technology company based in Atlanta, Georgia whose purpose is to make marketing more relevant and measurable through its Purchase Intelligence platform. Cardlytics partners with financial institutions to run their banking rewards program and in turn gains an insight to customer purchasing behavior. They then use these insights to help marketers identify, reach, and influence consumers as well as measure the true sales impact of marketing campaigns.